Hefei Hengxin Life Science and Technology Co., Ltd.
Hefei Hengxin Life Science and Technology Co., Ltd. engages in the research and development, production, and sale of polylactic acid products in China, North America, Europe, Australia, and internationally. It offers paper and clear cups, cup lids, knives, forks, spoons, straws, stirring roads, foaming tableware, food packaging containers, packing bags, cup holders, and cup sleeves. The company w… Read more
Hefei Hengxin Life Science and Technology Co., Ltd. (301501) - Total Liabilities
Latest total liabilities as of June 2025: CN¥659.01 Million CNY
Based on the latest financial reports, Hefei Hengxin Life Science and Technology Co., Ltd. (301501) has total liabilities worth CN¥659.01 Million CNY as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Hefei Hengxin Life Science and Technology Co., Ltd. - Total Liabilities Trend (2021–2024)
This chart illustrates how Hefei Hengxin Life Science and Technology Co., Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Hefei Hengxin Life Science and Technology Co., Ltd. Competitors by Total Liabilities
The table below lists competitors of Hefei Hengxin Life Science and Technology Co., Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Rechi Precision Co Ltd
TW:4532
|
Taiwan | NT$16.14 Billion |
|
WINBO-Dongjian Automotive Technology Co. Ltd.
SHE:300978
|
China | CN¥986.71 Million |
|
Avantel Limited
NSE:AVANTEL
|
India | ₹652.61 Million |
|
China Building Material
SHG:603060
|
China | CN¥3.08 Billion |
|
SK Chemicals Co Ltd Pref
KO:28513K
|
Korea | ₩2.60 Trillion |
|
Praram 9 Hospital Public Company Limited
BK:PR9
|
Thailand | ฿1.15 Billion |
|
Dirui Industrial Co Ltd
SHE:300396
|
China | CN¥889.04 Million |
|
Malteries Franco-Belges Société Anonyme
PA:MALT
|
France | €35.69 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down Hefei Hengxin Life Science and Technology Co., Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.50 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.33 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Hefei Hengxin Life Science and Technology Co., Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Hefei Hengxin Life Science and Technology Co., Ltd. (2021–2024)
The table below shows the annual total liabilities of Hefei Hengxin Life Science and Technology Co., Ltd. from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥869.40 Million | +25.91% |
| 2023-12-31 | CN¥690.49 Million | +22.06% |
| 2022-12-31 | CN¥565.71 Million | +129.91% |
| 2021-12-31 | CN¥246.05 Million | -- |